Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Evaluating the Impact of Cash Transfers on Tuberculosis (ExaCT TB): a stepped wedge cluster randomized controlled trial

Priya B. Shete, Jillian L. Kadota, Grace Nanyunja, Catherine Namale, Talemwa Nalugwa, Denis Oyuku, Stavia Turyahabwe, Noah Kiwanuka, Adithya Cattamanchi, Achilles Katamba
ERJ Open Research 2023; DOI: 10.1183/23120541.00182-2023
Priya B. Shete
1Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: priya.shete@ucsf.edu
Jillian L. Kadota
1Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jillian L. Kadota
Grace Nanyunja
2Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Namale
2Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talemwa Nalugwa
2Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Oyuku
2Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stavia Turyahabwe
3National Tuberculosis and Leprosy Programme, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noah Kiwanuka
4Department of Epidemiology & Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adithya Cattamanchi
1Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
2Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Achilles Katamba
2Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda
5Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background Mitigating financial barriers to tuberculosis (TB) diagnosis and treatment is a core priority of the global TB agenda. We evaluated the impact of a cash transfer (CT) intervention on completion of TB testing and treatment initiation in Uganda.

Methods We conducted a pragmatic complete stepped-wedge randomized trial of a one-time unconditional CT at ten health centers between September 2019-March 2020. People referred for sputum-based TB testing were enrolled to receive 20 000 Uganda Shillings (∼US$5·39) upon sputum submission. The primary outcome was the number initiating treatment for micro-bacteriologically confirmed TB within two weeks of initial evaluation. The primary analysis included cluster-level intent-to-treat and per-protocol analyses using negative binomial regression.

Results 4288 people were eligible. The number diagnosed with TB initiating treatment was higher in the intervention period versus the pre-intervention period (adjusted Rate Ratio (aRR)=1·34) with a 95% confidence interval (CI) of 0·62–2·91 (p=0·46), indicating a wide range of plausible true intervention effects. More were referred for TB testing (aRR=2·60, 95%CI: 1·86–3·62; p<0·001) and completed TB testing (aRR=3·22, 95%CI: 1·37–7·60; p=0·007) per National Guidelines. Results were similar, but attenuated in per-protocol analyses. Surveys revealed that while the CT supported testing completion, it was insufficient to address long-term underlying social/economic barriers.

Interpretation While it is uncertain whether a single unconditional CT increased the number of people diagnosed and treated for TB, it did support higher completion of diagnostic evaluation in a programmatic setting. A one-time CT may offset some but not all of the social/economic barriers to improving TB diagnosis outcomes.

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: The authors declare no competing interests.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Received February 16, 2023.
  • Accepted April 12, 2023.
  • Copyright ©The authors 2023
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

PreviousNext
Back to top
Vol 9 Issue 5 Table of Contents
ERJ Open Research: 9 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluating the Impact of Cash Transfers on Tuberculosis (ExaCT TB): a stepped wedge cluster randomized controlled trial
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Evaluating the Impact of Cash Transfers on Tuberculosis (ExaCT TB): a stepped wedge cluster randomized controlled trial
Priya B. Shete, Jillian L. Kadota, Grace Nanyunja, Catherine Namale, Talemwa Nalugwa, Denis Oyuku, Stavia Turyahabwe, Noah Kiwanuka, Adithya Cattamanchi, Achilles Katamba
ERJ Open Research Jan 2023, 00182-2023; DOI: 10.1183/23120541.00182-2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluating the Impact of Cash Transfers on Tuberculosis (ExaCT TB): a stepped wedge cluster randomized controlled trial
Priya B. Shete, Jillian L. Kadota, Grace Nanyunja, Catherine Namale, Talemwa Nalugwa, Denis Oyuku, Stavia Turyahabwe, Noah Kiwanuka, Adithya Cattamanchi, Achilles Katamba
ERJ Open Research Jan 2023, 00182-2023; DOI: 10.1183/23120541.00182-2023
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Virtual reality intervention alleviates dyspnea in patients recovering from COVID pneumonia
  • Clinical characteristics of chylothorax: results from the International Collaborative Effusion (ICE) database
  • Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
Show more Original research article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society